Insulet
PODD
$170.27
Share price
-0.97%
Change (1 day)
-46.60%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Net assets
Net assets on the balance sheet as of December 2023 : $0.73 B
According to Insulet's latest financial reports the company has $0.73 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Insulet - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.73 B | 53.8% |
| 2022-12-31 | $0.47 B | -14.36% |
| 2021-12-31 | $0.55 B | -7.84% |
| 2020-12-31 | $0.60 B | 695.26% |
| 2019-12-31 | $75.9 M | -64.21% |
| 2018-12-31 | $0.21 B | 33.8% |
| 2017-12-31 | $0.15 B | 151.02% |
| 2016-12-31 | $63.15 M | 85.46% |
| 2015-12-31 | $34.05 M | -59.38% |
| 2014-12-31 | $83.82 M | -32.72% |
| 2013-12-31 | $0.12 B | 182.05% |
| 2012-12-31 | $44.17 M | -46.61% |
| 2011-12-31 | $82.73 M | 24.92% |
| 2010-12-31 | $66.23 M | 25.3% |
| 2009-12-31 | $52.85 M | 88.06% |
| 2008-12-31 | $28.1 M | -69.54% |
| 2007-12-31 | $92.27 M | -190.67% |
| 2006-12-31 | $-0.11 B | 53.98% |
| 2005-12-31 | $-66.1 M | 48.49% |
| 2004-12-31 | $-44.51 M | 45.22% |
| 2003-12-31 | $-30.65 M | 64.32% |
| 2002-12-31 | $-18.66 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 9,286.38% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | 5,199.17% | 🇺🇸 USA |
 Medtronic MDT | $51.99 B | 6,996.49% | 🇮🇪 Ireland |
 Eli Lilly LLY | $10.86 B | 1,382.69% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.31 B | -57.20% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.12 B | 189.81% | 🇺🇸 USA |
 DexCom DXCM | $2.24 B | 206.65% | 🇺🇸 USA |